Congress, FDA Should Open Door for Generic Biologic Drugs

In a PAYGO world, this is $14 billion worth of savings just waiting there on the table. It's good for consumers, taxpayers, and policy-makers to create a clear regulatory pathway to get generic biologics to market. Biologics are great products and need as much competition as possible to be affordable enough for consumers.

More in Healthcare

ABLE: Opening doors of economic inclusion for persons with disabilities

Read more »